[beta]-lactam/[beta]-lactamase inhibitor combinations: from then to now.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Works matching IS 10600280 AND DT 2015 AND VI 49 AND IP 1
Results: 24
1
2
Criteria for prescribing dabigatrin extexilate and rivaroxaban really appropriate? Authors' reply.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
3
Reviewer Summary.
- Published in:
- Annals of Pharmacotherapy, 2015, v. 49, n. 1, p. 156, doi. 10.1177/1060028014564558
- Publication type:
- Article
4
Evaluation of Aspirin Use for Primary Prevention in Diabetic Patients.
- Published in:
- Annals of Pharmacotherapy, 2015, v. 49, n. 1, p. 150, doi. 10.1177/1060028014561083
- By:
- Publication type:
- Article
5
Potentially Suboptimal Prescribing for Older Veteran Nursing Home Patients With Dementia.
- Published in:
- Annals of Pharmacotherapy, 2015, v. 49, n. 1, p. 20, doi. 10.1177/1060028014558484
- By:
- Publication type:
- Article
6
Feasibility of a Patient-Centered Deprescribing Process to Reduce Inappropriate Use of Proton Pump Inhibitors.
- Published in:
- Annals of Pharmacotherapy, 2015, v. 49, n. 1, p. 29, doi. 10.1177/1060028014558290
- By:
- Publication type:
- Article
7
Adverse Reactions to Radiopharmaceuticals in France: Analysis of the National Pharmacovigilance Database.
- Published in:
- Annals of Pharmacotherapy, 2015, v. 49, n. 1, p. 39, doi. 10.1177/1060028014558153
- By:
- Publication type:
- Article
8
Vancomycin-Resistant Enterococcal Bacteremia Pharmacotherapy.
- Published in:
- Annals of Pharmacotherapy, 2015, v. 49, n. 1, p. 69, doi. 10.1177/1060028014556879
- By:
- Publication type:
- Article
9
A Randomized Trial of Loading Vancomycin in the Emergency Department.
- Published in:
- Annals of Pharmacotherapy, 2015, v. 49, n. 1, p. 6, doi. 10.1177/1060028014556813
- By:
- Publication type:
- Article
10
β-Lactam/β-Lactamase Inhibitor Combinations: From Then to Now.
- Published in:
- Annals of Pharmacotherapy, 2015, v. 49, n. 1, p. 86, doi. 10.1177/1060028014556652
- By:
- Publication type:
- Article
11
Criteria for Prescribing Dabigatrin Extexilate and Rivaroxaban Really Appropriate? Authors’ Reply.
- Published in:
- Annals of Pharmacotherapy, 2015, v. 49, n. 1, p. 155, doi. 10.1177/1060028014556118
- By:
- Publication type:
- Article
12
Criteria for Prescribing Dabigatrin Extexilate and Rivaroxaban Really Appropriate? Comment.
- Published in:
- Annals of Pharmacotherapy, 2015, v. 49, n. 1, p. 154, doi. 10.1177/1060028014555860
- By:
- Publication type:
- Article
13
Evaluation of Adjunctive Ketamine to Benzodiazepines for Management of Alcohol Withdrawal Syndrome.
- Published in:
- Annals of Pharmacotherapy, 2015, v. 49, n. 1, p. 14, doi. 10.1177/1060028014555859
- By:
- Publication type:
- Article
14
Severe Adverse Drug Reaction Following Crotalidae Polyvalent Immune Fab (Ovine) Administration for Copperhead Snakebite.
- Published in:
- Annals of Pharmacotherapy, 2015, v. 49, n. 1, p. 145, doi. 10.1177/1060028014555711
- By:
- Publication type:
- Article
15
Severe Romiplostim-Induced Rebound Thrombocytopenia After Splenectomy for Refractory ITP.
- Published in:
- Annals of Pharmacotherapy, 2015, v. 49, n. 1, p. 140, doi. 10.1177/1060028014555540
- By:
- Publication type:
- Article
16
Abiraterone Acetate-Induced Life-Threatening Torsade de Pointes.
- Published in:
- Annals of Pharmacotherapy, 2015, v. 49, n. 1, p. 152, doi. 10.1177/1060028014555362
- By:
- Publication type:
- Article
17
Features of Electronic Health Records Necessary for the Delivery of Optimized Anticoagulant Therapy: Consensus of the EHR Task Force of the New York State Anticoagulation Coalition.
- Published in:
- Annals of Pharmacotherapy, 2015, v. 49, n. 1, p. 113, doi. 10.1177/1060028014555176
- By:
- Publication type:
- Article
18
Achievement of Therapeutic Anti-Xa Levels in a Proven Heparin-Resistant Patient Through the Use of Nontraditional High-Dose Enoxaparin.
- Published in:
- Annals of Pharmacotherapy, 2015, v. 49, n. 1, p. 130, doi. 10.1177/1060028014554649
- By:
- Publication type:
- Article
19
Technosphere Insulin (Afrezza): A New, Inhaled Prandial Insulin.
- Published in:
- Annals of Pharmacotherapy, 2015, v. 49, n. 1, p. 99, doi. 10.1177/1060028014554648
- By:
- Publication type:
- Article
20
Ceritinib: A New Tyrosine Kinase Inhibitor for Non-Small-Cell Lung Cancer.
- Published in:
- Annals of Pharmacotherapy, 2015, v. 49, n. 1, p. 107, doi. 10.1177/1060028014553619
- By:
- Publication type:
- Article
21
Possible Amlodipine-Induced Hepatotoxicity After Stem Cell Transplant.
- Published in:
- Annals of Pharmacotherapy, 2015, v. 49, n. 1, p. 135, doi. 10.1177/1060028014552820
- By:
- Publication type:
- Article
22
The “Doctors” Will See You Now: A Pharmacist’s Take on the “Truth in Advertising” Campaign.
- Published in:
- Annals of Pharmacotherapy, 2015, v. 49, n. 1, p. 127, doi. 10.1177/1060028014552517
- By:
- Publication type:
- Article
23
Treatment of Acute Myeloid Leukemia During Pregnancy.
- Published in:
- Annals of Pharmacotherapy, 2015, v. 49, n. 1, p. 48, doi. 10.1177/1060028014552516
- By:
- Publication type:
- Article
24
Integrating Electronic Health Records in the Delivery of Optimized Anticoagulation Therapy.
- Published in:
- Annals of Pharmacotherapy, 2015, v. 49, n. 1, p. 125, doi. 10.1177/1060028014548570
- By:
- Publication type:
- Article